PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
15-Dec-2025 Budget speculation kills growth Institute of Economic Affairs
12-Dec-2025 CluePoints Scoops Prestigious 2025 Scrip Award CluePoints
11-Dec-2025 Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer Actithera
11-Dec-2025 Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting Lundbeck
11-Dec-2025 Ryvu Therapeutics Presents New Clinical Data from RIVER-81 and POTAMI-61 Studies of Romaciclib (RVU120) at the 2025 American Society of Hematology (ASH) Annual Meeting Ryvu Therapeutics
11-Dec-2025 Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology Oncoinvent
11-Dec-2025 Poolbeg Pharma plc - POLB 001 trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg Pharma
11-Dec-2025 Xinnate Receives FDA IND Approval for TCP-25, Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis Bullosa Xinnate
11-Dec-2025 Fibrocor Therapeutics appoints world-leading nephrologists to Clinical Advisory Board with a focus on its lead indication Alport Syndrome Fibrocor Therapeutics
11-Dec-2025 ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101 ProBioGen and Spica Therapeutics
11-Dec-2025 WORLD’S LEADING ANTIMALARIAL PRODUCT DEVELOPMENT PARTNERSHIP JOINS IICON CONSORTIUM IICON CONSORTIUM
11-Dec-2025 VPAG payment rate for newer medicines will be 14.5% in 2026 VPAG
11-Dec-2025 Perceptive eClinical Recognized as #1 Market Impact, and Overall, Leader in Everest Group’s PEAK Matrix® Assessment for RTSM Solutions 2025 Perceptive eClinical
11-Dec-2025 Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut Allergy Mabylon AG
10-Dec-2025 Mindpeak Secures First Patent for Advanced AI Method in Digital Pathology Mindpeak
10-Dec-2025 Lack of education causes patients to stop vital treatments, survey finds Cognitant Group Ltd
10-Dec-2025 UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder UCB
09-Dec-2025 Poolbeg Pharma plc - POLB 001 trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg Pharma
05-Dec-2025 7 Million Psoriasis Patients See New Hope: China Launches Its First IL-23p19 Inhibitor Picankibart dengyuemed
04-Dec-2025 Biocair Strengthens Global Network and Sustainability Commitments in 2025 Biocair